Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 100

Sort by

Sort Order Select

Journal Articles

Erythroferrone Regulates Bone Remodeling in β-Thalassemia

Melanie Castro-Mollo, MD, Marc Ruiz Martinez, PhD, Maria Feola, PhD, Anisa Azatovna Gumerova, MD, Carla Casu, PhD, Robert E Fleming, MD, Stefano Rivella, PhD, Tony Yuen, PhD, Mone Zaidi, MD PhD, Yelena Ginzburg, MD

Blood (2019) 134 (Supplement_1): 2.

https://doi.org/10.1182/blood-2019-125822

Published: 2019

Journal Articles

Thrombin: A Driver or Attenuator of Bone Disease on Hemophilia?

Galen Goldscheitter, BS, BA, Robert Klein, MD, Jason A Taylor, MD PhD

Blood (2019) 134 (Supplement_1): 4916.

https://doi.org/10.1182/blood-2019-130698

Published: 2019

Journal Articles

Acute Myeloid Leukemia Induced Remodelling of the Human Bone Marrow Niche Predicts Clinical Outcome

Yiyang Chen, Yasmin Zaun, MD, Lucas Arnold, Kerstin Weissenfels, Kurt Werner Schmid, Ludger Klein-Hitpass, PhD, Anthony Squire, Stefanie Bertram, MD, Ulrich Duehrsen, MD, Maher Hanoun, MD

Blood (2018) 132 (Supplement 1): 3851.

https://doi.org/10.1182/blood-2018-99-116317

Published: 2018

Journal Articles

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Sahar Hiram-Bab, PhD, Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Nathalie Ben-Califa, PhD, Tamar Liron, PhD, Martina Rauner, PhD, Ben Wielockx, PhD, Moshe Mittelman, MD, Howard S. Oster, MD PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2018) 132 (Supplement 1): 846.

https://doi.org/10.1182/blood-2018-99-111643

Published: 2018

Journal Articles

Nocturnal Melatonin Renews Bone and Blood Forming Stem Cells Reservoir By Metabolic Reprograming

Karin Golan, PhD, Mayla Bertagna, MSc, Suditi Bhattacharya, MSc, Anoop Babu-Vasandan, PhD, Francesca Avemaria, PhD, Eman Khatib-Massalha, MSc, Zulma S. Ferreira, PhD, Orit Kollet, PhD, Abraham Avigdor, MD, Regina P. Markus, PhD, Tsvee Lapidot, PhD

Blood (2018) 132 (Supplement 1): 3326.

https://doi.org/10.1182/blood-2018-99-118354

Published: 2018

Journal Articles

Heterozygous CTC1 Variants in Acquired Bone Marrow Failure

Wenyi Shen, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Reda Z. Mahfouz, MD PhD, Tomas Radivoyevitch, Louis Williams, MD MBA, Mohammad Fahad B. Asad, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 3866.

https://doi.org/10.1182/blood-2018-99-115193

Published: 2018

Journal Articles

Identification and Molecular Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Niche Factor

Keane Jared Guillaume Kenswil, BSc, MSc, Christopher Adrian Jaramillo, MD, Zhen Ping, MSc, Si Chen, MSc, Remco Michiel Hoogenboezem, MSc, Maria Athina Mylona, PhD, Maria Niken Adisty, BSc, Eric Moniqué Johannes Bindels, PhD, Hans Stoop, PhD, King Hong Lam, MD PhD, Pieter Koen Bos, MD, Bram van Eerden, PhD, Tom Cupedo, PhD, Marc Hermanus Gerardus Petrus Raaijmakers, MD PhD

Blood (2017) 130 (Supplement 1): 2437.

https://doi.org/10.1182/blood.V130.Suppl_1.2437.2437

Published: 2017

Journal Articles

Clot Formation Under Physiological Flow Conditions Is Altered in Sickle Cell Disease As Measured By a Multiparameter Microfluidic System

Abhijit Ravindran, John Baek, BS, David R. Myers, PhD, Wilbur A. Lam, MDPhD

Blood (2017) 130 (Supplement 1): 539.

https://doi.org/10.1182/blood.V130.Suppl_1.539.539

Published: 2017

Journal Articles

Factor VIII Plays a Direct Role in Osteoblast Development

Emily Ann Larson, BS, Jason A Taylor, MD PhD

Blood (2017) 130 (Supplement 1): 3661.

https://doi.org/10.1182/blood.V130.Suppl_1.3661.3661

Published: 2017

Journal Articles

Protein Kinase CSNK1A Regulates the Multiple Myeloma Plasma Cell-Microenvironment Interplay

Sabrina Manni, PhD, Ketty Gianesin, PhD, Marilena Carrino, PhD, Federica Costa, PhD, Gregorio Barilà, MD, Renato Zambello, MD, Nicola Giuliani, MD PhD, Livio Trentin, MD, Gianpietro Semenzato, MD, Francesco Piazza, MD

Blood (2017) 130 (Supplement 1): 4398.

https://doi.org/10.1182/blood.V130.Suppl_1.4398.4398

Published: 2017

Journal Articles

Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Inhibits Osteoclast Activity and Restores Osteoblast Activity in a Murine Model of Multiple Myeloma Bone Disease

Josephine Muller, Arnold Bolomsky, PhD, Kathrin Schonfelder, Frederic Baron, Yves Beguin, MD PhD, Heinz Ludwig, MD, Jo Caers, MD, Roy Heusschen, PhD

Blood (2017) 130 (Supplement 1): 4416.

https://doi.org/10.1182/blood.V130.Suppl_1.4416.4416

Published: 2017

Journal Articles

Aplidin (Plitidepsin) Regulates Viability and Function of Myeloma Cells and Bone Cells in Combination with Other Anti-MM Drugs

Jesus Delgado-Calle, PhD, Emily G Atkinson, Jessica Nelson, Noriyoshi Kurihara, DDS, PhD, Carlos Galmarini, David David Roodman, MD PhD, Teresita Bellido

Blood (2017) 130 (Supplement 1): 3065.

https://doi.org/10.1182/blood.V130.Suppl_1.3065.3065

Published: 2017

Journal Articles

The Mechanisms of PIM Kinase Inhibitor, SGI-1776 Free Base, in Treating Myeloma-Associated Bone Disease

Qingxiao Chen, MS, Jingsong He, MD, Huiyao Gu, Xi Huang, MD, Jing Chen, MD, Zhang En Fan, Xing Guo, MD, Haimeng Yan, He Huang, MD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 3079.

https://doi.org/10.1182/blood.V130.Suppl_1.3079.3079

Published: 2017

Journal Articles

Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)

Adam Pagenkopf, Binod Dhakal, MBBS, Chelsea L. Hope, PhD, Athanasios Papadas, MD, Michael G Johnson, PhD, Bradley Nagel, Elena Kurudza, Samik Partha, Bianca Ruffolo, Catherine Leith, MBBChir, Shigeki Miyamoto, PhD, Peiman Hematti, MD, Parameswaran Hari, MD MRCP, MS, Natalie Scott Callander, MD, Fotios Asimakopoulos, PhDMBBChir,

Blood (2017) 130 (Supplement 1): 1756.

https://doi.org/10.1182/blood.V130.Suppl_1.1756.1756

Published: 2017

Journal Articles

p62-ZZ Domain Signaling Inhibition Rescues MM-Induced Epigenetic Repression at the Runx2 promoter and Allows Osteoblast Differentiation of MM Patient Pre-Osteoblasts In Vitro

Rebecca Silbermann, MD, Juraj Adamik, PhD, Dan Zhou, Xiang-Qun Xie, MD PhD EMBA, Noriyoshi Kurihara, DDS, PhD, G. David Roodman, MD PhD, Deborah Lynn Galson, PhD

Blood (2016) 128 (22): 4410.

https://doi.org/10.1182/blood.V128.22.4410.4410

Published: 2016

Journal Articles

Decreased In Vitro Osteoblast Mineralization in Primary Bone Marrow Stromal Cells (MSCs) Derived from FVIII-Deficient Mice

Emily A Larson, Jason A Taylor, MD PhD

Blood (2016) 128 (22): 560.

https://doi.org/10.1182/blood.V128.22.560.560

Published: 2016

Journal Articles

Low-Iron Diet and Chelation Therapy Rescue Severe Atherosclerosis Associated with High Circulating Iron Levels

Francesca Vinchi, PhD, Andreas Simmelbauer, Master student, Sandro Altamura, PhD, Sebastian Spaich, Richard Sparla, Bruno Galy, PhD, Matthias W. Hentze, MD, Martina U. Muckenthaler, PhD

Blood (2016) 128 (22): 199.

https://doi.org/10.1182/blood.V128.22.199.199

Published: 2016

Journal Articles

Key Presenting Signs and Patient Co-Variables in Early Diagnosis of Type 3 Gaucher Disease: A Global Delphi Consensus Initiative

David J Kuter, MD DPhil, Sam Salek, PhD, Atul Mehta, MD

Blood (2016) 128 (22): 4886.

https://doi.org/10.1182/blood.V128.22.4886.4886

Published: 2016

Journal Articles

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

Juraj Adamik, PhD, Rebecca Silbermann, MD, Konstantinos Lontos, MD, Peng Zhang, PhD, Quanhong Sun, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD

Blood (2016) 128 (22): 3247.

https://doi.org/10.1182/blood.V128.22.3247.3247

Published: 2016

Journal Articles

Novel Biologic Therapy for Untreated Diseases of Vascular Calcification

Demetrios T. Braddock, MD PhD, Dillon Kavanagh, Xiaofeng Li, PhD

Blood (2016) 128 (22): 2326.

https://doi.org/10.1182/blood.V128.22.2326.2326

Published: 2016

NARROW

Erythroferrone Regulates Bone Remodeling in β-Thalassemia

Thrombin: A Driver or Attenuator of Bone Disease on Hemophilia?

Acute Myeloid Leukemia Induced Remodelling of the Human Bone Marrow Niche Predicts Clinical Outcome

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Nocturnal Melatonin Renews Bone and Blood Forming Stem Cells Reservoir By Metabolic Reprograming

Heterozygous CTC1 Variants in Acquired Bone Marrow Failure

Identification and Molecular Characterization of Endothelial Cells Associated with Hematopoietic Niche Formation in Humans Identifies IL-33 As an Anabolic Niche Factor

Clot Formation Under Physiological Flow Conditions Is Altered in Sickle Cell Disease As Measured By a Multiparameter Microfluidic System

Factor VIII Plays a Direct Role in Osteoblast Development

Protein Kinase CSNK1A Regulates the Multiple Myeloma Plasma Cell-Microenvironment Interplay

Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Inhibits Osteoclast Activity and Restores Osteoblast Activity in a Murine Model of Multiple Myeloma Bone Disease

Aplidin (Plitidepsin) Regulates Viability and Function of Myeloma Cells and Bone Cells in Combination with Other Anti-MM Drugs

The Mechanisms of PIM Kinase Inhibitor, SGI-1776 Free Base, in Treating Myeloma-Associated Bone Disease

Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)

p62-ZZ Domain Signaling Inhibition Rescues MM-Induced Epigenetic Repression at the Runx2 promoter and Allows Osteoblast Differentiation of MM Patient Pre-Osteoblasts In Vitro

Decreased In Vitro Osteoblast Mineralization in Primary Bone Marrow Stromal Cells (MSCs) Derived from FVIII-Deficient Mice

Low-Iron Diet and Chelation Therapy Rescue Severe Atherosclerosis Associated with High Circulating Iron Levels

Key Presenting Signs and Patient Co-Variables in Early Diagnosis of Type 3 Gaucher Disease: A Global Delphi Consensus Initiative

EZH2 Inhibitor GSK126 Exhibits Osteo-Anabolic Properties in MM Bone Disease and Synergizes with Bortezomib to Inhibit MM Cell Viability

Novel Biologic Therapy for Untreated Diseases of Vascular Calcification

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only